DUBLIN--(BUSINESS WIRE)--The "Innovations
in Drug Discovery and Development for Neurological, Cancer, and
Cardiovascular Applications" report has been added to ResearchAndMarkets.com's
offering.
This Drug Discovery TechVision Opportunity Engine (TOE) depicts new life sciences trends across drug discovery platforms focused on neurological, oncological, and cardiovascular application areas.
In vivo, in vitro, and in silico models are depicted, integrating the
remarkable synergy among biological innovations such as checkpoint
inhibitors, stem cells, and transposons, and machine learning artificial
intelligence-based approaches. Clinical trials for treatments based on
RNA targeting technologies are also depicted.
Key Topics Covered
1. Recent Innovations in Drug Discovery Platforms
- Developing Animal Models with Human Brain Organoids
- Novel Disease Model to Help Develop Immunotherapy against Neurodegenerative Disorders
- Advanced Human Tumor Eliminated by Zika Virus in Animal Model
- CGRP Inhibitor Shows Great Clinical Promise in Migraine Prevention and Treatment
- Targeting KRAS for Cancer Management
- Tolperisone Formulation for Neuromuscular Spasms that Meets North American Guidelines
- Technology Convergence for Regenerative Cardiovascular Therapy
- Leveraging Autophagy for Therapeutic Breakthroughs
- Machine Learning Platforms for Drug Development
2. Drug DiscoveryTechnology Focus and Trends
- Clinical Trial Analysis
- Industry Interactions
For more information about this report visit https://www.researchandmarkets.com/research/cjdh2g/innovations_in?w=4
